Zalicus Inc.

zalicus.com
245 First St
Cambridge, MA 02142
Phone:617-301-7000
Fax:617-301-7010
Ticker: ZLCS

Type:

Public

Employees:

< 5

Revenue:

10 - 20 Million

Industry:

Biotech/Healthcare->BioTech/Drugs

SIC Code:

2834 - Pharmaceutical Preparations
Click to Open Details Click to Close Details
Click to Open Details
Mark Corrigan
Title: CEO
Not Available Executive HQ :617-301-7000 Sign Up Sign Up
Justin Renz
Title: CFO/EVP/Treasurer
Not Available Finance HQ :617-301-7000 Sign Up Sign Up
Danielle Lafrance
Title: Assistant to the COO
Not Available Operations HQ :617-301-7000 Sign Up Sign Up
Gina Nugent
Title: VP, Investor Relations/Corporate Communications
Not Available Public Relations 617-301-7099 Sign Up Sign Up
Grant Zimmermann
Title: Director of Screening/Technology Development
Not Available Executive HQ :617-301-7000 Sign Up Sign Up
Sarah Larson
Title: Staffing Manager
Not Available Executive HQ :617-301-7000 Sign Up Sign Up
Kate Findlen
Title: Director of Clinical Operations
Not Available Executive 617-425-7000 Sign Up Sign Up
Emilie Webster
Title: Strategic Marketing Manager
Not Available Sales - Marketing HQ :617-301-7000 Sign Up Sign Up
Darrin Sloan
Title: Clinical Supply Assoc
Not Available Executive HQ :617-301-7000 Sign Up Sign Up
Showing 1 to 9 of 9 entries

Click to Open Details Click to Close Details
Click to Close Details
Click to Close Details
GENERAL
img

Click to Close Details

Poll Question

Date Created

Current Result

Votes

Additional Info:

This includes Zalicus Inc. email format addresses with the @zalicus.com domain, contacts, phone numbers, linkedin info, cfo employees, and facebook profiles. Zalicus Inc. is a Biotech/drugs business with its headquarters based in Cambridge, MA. If you sign up for our free trial you will see our email@zalicus.com addresses.

Company Background:

Full company description is available with the free trial.

Ceo Reference:

Mark Corrigan
Zalicus Inc.'s CEO is Mark Corrigan. They are based in Cambridge, MA, and you can find their Lead411 profile filed under the Biotech/drugs industry. Mark Corrigan's profile contains twitter, phone numbers, linkedin, wiki, and biography information, and you can also find other Zalicus Inc. contact information and email addresses on Lead411 with the @zalicus.com domain format. Some possible email formats for Mark Corrigan are MCorrigan@zalicus.com, Mark.Corrigan@zalicus.com, Mark@zalicus.com, and Mark_Corrigan@zalicus.com. If you sign up for our free trial you will see our email@zalicus.com addresses.

Similar Companies:

Cubist Pharmaceuticals, Inc.
The company profile also contains facebook info, phone numbers, linkedin accounts, cfo contacts, and Cubist Pharmaceuticals, Inc. email format addresses with the domain of @cubist.com. Cubist Pharmaceuticals, Inc., a Biotech/drugs company has its main office in Lexington, MA. If you sign up for our free trial you will see our email@cubist.com addresses.
Curis, Inc
If you don't want to waste too much time looking for company information regarding Curis, Inc, a Biotech/drugs company, check out their Lead411 profile. Our profiles have linkedin data, phone numbers, cfo contacts, and more. It contains helpful contact information regarding top company officials, including that of Curis, Inc's CEO Ali Fattaey, and other Curis, Inc email format addresses within the @curis.com domain. Curis, Inc is based in Lexington, MA. If you sign up for our free trial you will see our email@curis.com addresses.
ArQule, Inc.
If you don't want to waste too much time looking for company information regarding Arqule, Inc., a Biotech/drugs company, check out their Lead411 profile. Our profiles have linkedin data, phone numbers, cfo contacts, and more. It contains helpful contact information regarding top company officials, including that of Arqule, Inc.'s CEO Paolo Pucci, and other Arqule, Inc. email format addresses within the @arqule.com domain. Arqule, Inc. is based in Woburn, MA. If you sign up for our free trial you will see our email@arqule.com addresses.
© 2014 Lead411 Corporation. All Rights Reserved.